TheraRadar
← Back
Data updated: Jun 28, 2026

MLV

Generics
Pharmaceuticals

MLV is a generic drug manufacturer with 3 FDA-approved products.

2009
Since
3
Drugs
-
Trials
1
New Drugs (2yr)

MLV's Key Drugs

MLV's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

MLV's Recent FDA Approvals

MLV secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.

PYRIDOSTIGMINE BROMIDE NDA
2024-10-04
pyridostigmine bromide
INDICATIONS AND USAGE Pyridostigmine Bromide Tablets USP are useful in the treatment of myasthenia gravis.

MLV's Therapeutic Areas

Disease areas where MLV has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

MLV Pipeline Snapshot

Active clinical trials for MLV across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling